Use Aegerion Pharmaceuticals Inc news within your existing portfolios mixed with equities fromn NASDAQ to enhance returns of your portfolios as well as to determine Stock diversification method that is right for you.
Aegerion RevenueAegerion Pharmaceuticals Inc is rated below average in revenue category among related companies. Market size based on revenue of Biotechnology industry is presently estimated at about 49.22 Billion. Aegerion adds roughly 24.05 Million in revenue claiming only tiny portion of stocks in Biotechnology industry.
Aegerion vs. Gilead
Aegerion Total Debt
Based on latest financial disclosure Aegerion Pharmaceuticals Inc has Total Debt of 8.48 M. This is 99.47% lower than that of Healthcare sector, and 99.2% lower than that of Biotechnology industry, The Total Debt for all stocks is 99.88% higher than the company.
Follow Aegerion News with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker